Verrica Pharmaceuticals Inc. (VRCA) News Headlines

▮ More

Date

Headline

6/28/2022 7:59:56 AM Verrica Pharma Holds Type A Meeting With FDA Regarding Path Forward For NDA For VP-102

6/28/2022 7:41:24 AM Verrica Pharmaceuticals Holds Type A Meeting With FDA For VP-102 For Molluscum Contagiosum

5/25/2022 7:16:26 AM Why Verrica Pharma Stock Falling In Pre-market?

5/25/2022 7:07:47 AM Pre-market Movers: VRCA, CMRA, WEN, SPRC, NEGG…

5/25/2022 6:41:50 AM Verrica Gets CRL From FDA For VP-102 NDA For The Treatment Of Molluscum Contagiosum

5/2/2022 12:05:13 AM Biotech Stocks Facing FDA Decision In May 2022

4/5/2022 7:40:31 AM Verrica Pharma Doses First Patient In Phase 2 Study Of LTX-315 For Basal Cell Carcinoma

11/29/2021 7:51:07 AM Verrica Pharma Announces Resubmission Of NDA For VP-102 For Molluscum Contagiosum

11/18/2021 7:40:19 AM Verrica Pharma Announces FDA Acceptance Of IND Application For LTX-315 For Basal Cell Carcinoma

11/12/2021 7:37:38 AM Verrica Pharma Q3 GAAP Net Loss $12.8 Mln Or $0.47/Shr Vs Loss Of $10.5 Mln Or $0.42/Shr Last Year

9/20/2021 6:19:21 PM Verrica Pharma Tanks 25% After Receiving Complete Response Letter From FDA

8/30/2021 2:43:24 AM Biotech Stocks Facing FDA Decision In September 2021

8/10/2021 9:26:51 AM Verrica Pharma Q2 Loss Per Share $0.43; Non-GAAP Loss Per Share $0.35

7/9/2021 7:58:08 AM Verrica Pharma Appoints Terry Kohler As CFO

5/28/2021 8:05:16 AM Verrica Pharmaceuticals Says FDA Extended Review Period For Its NDA For VP-102

3/22/2021 10:45:46 PM Verrica Pharma Prices Public Offering Of 2.03 Mln Shares At $14.75/shr

3/4/2021 7:47:00 AM Verrica Pharmaceuticals Q4 Net Loss $13.0 Mln Vs Loss $7.6 Mln Last Year

Older Articles